Primary progressive aphasia (PPA) is a form of dementia characterized by degeneration of the language network. In the early stages, PPA is associated with a left-lateralized pattern of cortical atrophy … Continue Reading Neuroimaging can identify start and location of amyloid plaques in living brain.
With Alzheimer’s disease medical professionals have to conduct costly brain imaging scans, and sometimes, invasive cerebral spinal fluid tests to rule out other diseases. Now, a new study from researchers … Continue Reading Human study identifies biomarker in blood for Alzheimer’s disease.
Alzheimer’s disease poses a health problem of pandemic proportions. It is estimated that by the year 2030 there will be greater than 60 million people worldwide with AD, and $375 … Continue Reading Newly identified role for ApoE explains its effects in Alzheimer’s.
It has been known for some years that Alzheimer’s disease is characterised by two types of lesions, amyloid plaques and degenerated tau protein. The amyloid component and altered cholesterol metabolism … Continue Reading Study shows link between the tau component of Alzheimer’s and cholesterol.
Examining post-mortem tissue from the brains of people with Alzheimer’s disease, Stanford University researchers state they have identified what appear to be iron-containing microglia, specialized scavenger cells that sometimes become … Continue Reading A human study identifies region specific iron-containing microglia in Alzheimer’s brains.
Through studying brain scans and cerebrospinal fluid of healthy adults researchers at Washington University have shown that changes in key biomarkers of Alzheimer’s disease during midlife can help identify those who … Continue Reading First ever large-scale human study validates multiple biomarkers for Alzheimer’s disease.
Degeneration of the white matter of the brain may be an early marker of specific types of Alzheimer’s disease (AD), including early-onset AD, according to results of a new study … Continue Reading Researchers identify specific types of Alzheimer’s disease using white matter neuroimaging test.
Researchers have uncovered a unique connection between diabetes and Alzheimer’s disease, providing further evidence that a disease that robs people of their memories may be affected by elevated blood sugar, … Continue Reading Scientists find new link between diabetes and Alzheimer’s disease.
After six years of painstaking research, a UCLA-led team has validated the first standardized protocol for measuring one of the earliest signs of Alzheimer’s disease, the atrophy of the part … Continue Reading Harmonized neuroimaging protocol for measuring early sign of Alzheimer’s has been developed.
The pathological process amyloidosis, in which misfolded proteins, amyloids, form insoluble fibril deposits, occurs in many diseases, including Alzheimer’s disease and type 2 diabetes mellitus. However, little is known about … Continue Reading Researchers identify amyloid formation link between Alzheimer’s disease and T2 diabetes.
Changes in brain connections visible on MRI could represent an imaging biomarker of Alzheimer’s disease, according to a new study presented at the annual meeting of the Radiological Society of … Continue Reading Neuroimaging shows brain connection breakdown in early Alzheimer’s disease.